We are live on ! Find out more
QGENF

QIAGEN NV
QGENF

Delisted

QGENF was delisted on the 14th of February, 2005.

165 hedge funds and large institutions have $2.5B invested in QIAGEN NV in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 55 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $284K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

100% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 16

18% more capital invested

Capital invested by funds: $2.12B → $2.5B (+$381M)

10% more funds holding

Funds holding: 150165 (+15)

4% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 55

Holders
165
Holders Change
+15
Holders Change %
+10%
% of All Funds
4.79%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
32
Increased
53
Reduced
55
Closed
16
Calls
$1.01M
Puts
$284K
Net Calls
+$727K
Net Calls Change
-$368K
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
176
California Public Employees Retirement System
California
-$225K -10,500 Closed
WMSA
177
Weiss Multi-Strategy Advisers
New York
-$214K -10,000 Closed
M&T Bank
178
M&T Bank
New York
-$97K -4,530 Closed
MAA
179
Managed Account Advisors
New Jersey
-$56K -2,635 Closed
HF
180
Hoxton Financial
West Virginia
-$5K -216 Closed
FBC
181
Fairfield, Bush & Co
Connecticut
-$3K -148 Closed

QGENF Hedge Fund Activity: Q4 2013 in Review

165 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q4 2013, worth a combined $2.5B — up 18% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new QGENF positions and 16 closed out — a net gain of 16 holders — while 53 added to existing stakes and 55 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $45.9M. The largest seller was Credit Agricole, cutting an estimated $39.4M.

  • 165 institutional investors held QIAGEN NV (QGENF) as of Q4 2013, up from 150 in Q3 2013.
  • Funds reported $2.5B of QIAGEN NV stock for Q4 2013, up 18% quarter-over-quarter.
  • 32 funds opened new QIAGEN NV positions in Q4 2013 and 16 closed out, a net change of +16 holders.
  • The largest QIAGEN NV buyer in Q4 2013 was OrbiMed, an estimated $45.9M added.
  • The largest QIAGEN NV seller in Q4 2013 was Credit Agricole, an estimated $39.4M sold.

Based on aggregated 13F filings for Q4 2013.